Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.64 |
| ▸ | HPGD | P15428 | 9/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | STS | P08842 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | PRKDC | P78527 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 4/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 2/20 | 0.53 |
| ▸ | CASP1 | P29466 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30636721 | 1.00 | ALDH1A1 (0.64) | ALDH1A1KDM4EHPGDHSD17B10MAOA | |
| SCHEMBL724134 | 0.84 | ALDH1A1 (0.68) | ALDH1A1KDM4EHPGDHSD17B10MAOA | |
| SCHEMBL27523022 | 0.82 | ALDH1A1 (0.62) | ALDH1A1KDM4EHPGDHSD17B10MAOA | |
| Hydrochloric Acid SCHEMBL30117164 | 0.82 | ALDH1A1 (0.66) | ALDH1A1KDM4EHPGDHSD17B10MAOA | |
| SCHEMBL11828153 | 0.82 | NQO1 (0.58) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| SCHEMBL2490464 | 0.81 | PIM1 (0.64) | ALDH1A1KDM4EHPGDHSD17B10AKR1B1 | |
| SCHEMBL5456535 | 0.81 | ALDH1A1 (0.51) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| SCHEMBL31290722 | 0.81 | PIM1 (0.64) | ALDH1A1KDM4EHPGDHSD17B10AKR1B1 | |
| SCHEMBL31506370 | 0.81 | ALDH1A1 (0.51) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| SCHEMBL128001 | 0.81 | KDM4E (0.74) | ALDH1A1KDM4EHPGDHSD17B10MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117024253-A | Preparation method of medicinal thymol specific impurity | 江西阿尔法高科药业有限公司 | 2023-11-10 | — | — | CN | claimed |
| US-9127092-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2015-09-08 | — | — | US | claimed |
| US-20140187725-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2014-07-03 | — | — | US | claimed |
| CN-117024253-A | Preparation method of medicinal thymol specific impurity | 江西阿尔法高科药业有限公司 | 2023-11-10 | — | — | CN | disclosed |
| US-20210135115-A1 | PHOTOCROSSLINKABLE POLYMER, INSULATING FILM, PLANARIZATION FILM, LYOPHILIC/LIQUID REPELLENT PATTERNED FILM, AND ORGANIC FIELD EFFECT TRANSISTOR DEVICE COMPRISING SAME | TOSOH CORPORATION (JP) | 2021-05-06 | — | — | US | disclosed |
| US-20190055283-A1 | AZA-PEPTIDE ALDEHYDES AND KETONES | OHIO STATE INNOVATION FOUNDATION | 2019-02-21 | — | — | US | disclosed |
| US-9212187-B2 | Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9212187-B2 | Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9127092-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2015-09-08 | — | — | US | disclosed |
| CN-103554074-B | Preparation method of 3-trifluoromethyl coumarin derivative | UNIV SOOCHOW | 2015-03-25 | — | — | CN | disclosed |
| US-20140343277-A1 | NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION | OTSUKA PHARCACEUTICAL CO LTD (JP) | 2014-11-20 | — | — | US | disclosed |
| US-7615332-B2 | Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process | CANON KABUSHIKI KAISHA (JP) | 2009-11-10 | — | — | US | disclosed |
| US-20090233232-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | CANON KABUSHIKI KAISHA (JP) | 2009-09-17 | — | — | US | disclosed |
| CN-101497632-A | Method for synthesizing coumarin-3-phosphonate derivative | UNIV SOOCHOW (CN) | 2009-08-05 | — | — | CN | disclosed |
| EP-1956430-A1 | Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process | Canon Kabushiki Kaisha (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-20080187864-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | CANON KABUSHIKI KAISHA (JP) | 2008-08-07 | — | — | US | disclosed |
| US-7220467-B2 | Photo-alignment material and liquid crystal display device and its manufacturing method using the same | LG.PHILLIPS LCD CO., LTD. (KR) | 2007-05-22 | — | — | US | disclosed |
| US-7220467-B2 | Photo-alignment material and liquid crystal display device and its manufacturing method using the same | LG.PHILLIPS LCD CO., LTD. (KR) | 2007-05-22 | — | — | US | disclosed |
| WO-2007026959-A2 | DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-03-08 | — | — | WO | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343277-A1 | NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION | KCNH2, KCNH1, KCNH3 | ALDH1A1 3259/4885KDM4E 1288/4885HPGD 1987/4885 |
| US-20090233232-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | FRG1, PAH, RER1 | ALDH1A1 1256/4885KDM4E 2439/4885HPGD 2184/4885 |
| US-20080187864-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | FRG1, PAH, RER1 | ALDH1A1 1256/4885KDM4E 2439/4885HPGD 2184/4885 |
| US-20190055283-A1 | AZA-PEPTIDE ALDEHYDES AND KETONES | VIP, DNPEP, PEPD | ALDH1A1 153/4885KDM4E 591/4885HPGD 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.